COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES

This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequenti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAREN JEAN FERRANTE, DIANE INGEBORG HEALEY, JEAN SACCUZZO BEEBE, JAMES JOHN O'LEARY, JITESH PRANLAL JANI, TRACEY LEE SCHAEFFER
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KAREN JEAN FERRANTE
DIANE INGEBORG HEALEY
JEAN SACCUZZO BEEBE
JAMES JOHN O'LEARY
JITESH PRANLAL JANI
TRACEY LEE SCHAEFFER
description This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan, and Camptosar(R), an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypertensive agent.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HK1079106A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HK1079106A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HK1079106A13</originalsourceid><addsrcrecordid>eNrjZDBx9vcN8A_2DPH091Nw8w9SCAlydQzx9HNX8IgMcA0KCPL38XRzDQIKhbkquHgGuzoGuwbzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4D29DA3NLQwMzR0NjIpQAALkNJ30</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES</title><source>esp@cenet</source><creator>KAREN JEAN FERRANTE ; DIANE INGEBORG HEALEY ; JEAN SACCUZZO BEEBE ; JAMES JOHN O'LEARY ; JITESH PRANLAL JANI ; TRACEY LEE SCHAEFFER</creator><creatorcontrib>KAREN JEAN FERRANTE ; DIANE INGEBORG HEALEY ; JEAN SACCUZZO BEEBE ; JAMES JOHN O'LEARY ; JITESH PRANLAL JANI ; TRACEY LEE SCHAEFFER</creatorcontrib><description>This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan, and Camptosar(R), an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypertensive agent.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060331&amp;DB=EPODOC&amp;CC=HK&amp;NR=1079106A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060331&amp;DB=EPODOC&amp;CC=HK&amp;NR=1079106A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAREN JEAN FERRANTE</creatorcontrib><creatorcontrib>DIANE INGEBORG HEALEY</creatorcontrib><creatorcontrib>JEAN SACCUZZO BEEBE</creatorcontrib><creatorcontrib>JAMES JOHN O'LEARY</creatorcontrib><creatorcontrib>JITESH PRANLAL JANI</creatorcontrib><creatorcontrib>TRACEY LEE SCHAEFFER</creatorcontrib><title>COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES</title><description>This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan, and Camptosar(R), an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypertensive agent.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBx9vcN8A_2DPH091Nw8w9SCAlydQzx9HNX8IgMcA0KCPL38XRzDQIKhbkquHgGuzoGuwbzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4D29DA3NLQwMzR0NjIpQAALkNJ30</recordid><startdate>20060331</startdate><enddate>20060331</enddate><creator>KAREN JEAN FERRANTE</creator><creator>DIANE INGEBORG HEALEY</creator><creator>JEAN SACCUZZO BEEBE</creator><creator>JAMES JOHN O'LEARY</creator><creator>JITESH PRANLAL JANI</creator><creator>TRACEY LEE SCHAEFFER</creator><scope>EVB</scope></search><sort><creationdate>20060331</creationdate><title>COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES</title><author>KAREN JEAN FERRANTE ; DIANE INGEBORG HEALEY ; JEAN SACCUZZO BEEBE ; JAMES JOHN O'LEARY ; JITESH PRANLAL JANI ; TRACEY LEE SCHAEFFER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HK1079106A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KAREN JEAN FERRANTE</creatorcontrib><creatorcontrib>DIANE INGEBORG HEALEY</creatorcontrib><creatorcontrib>JEAN SACCUZZO BEEBE</creatorcontrib><creatorcontrib>JAMES JOHN O'LEARY</creatorcontrib><creatorcontrib>JITESH PRANLAL JANI</creatorcontrib><creatorcontrib>TRACEY LEE SCHAEFFER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAREN JEAN FERRANTE</au><au>DIANE INGEBORG HEALEY</au><au>JEAN SACCUZZO BEEBE</au><au>JAMES JOHN O'LEARY</au><au>JITESH PRANLAL JANI</au><au>TRACEY LEE SCHAEFFER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES</title><date>2006-03-31</date><risdate>2006</risdate><abstract>This invention relates a method of treating hyperproliferative diseases. More particularly, the present invention relates to a method of treating hyperproliferative diseases, such as cancer, comprising the step of administering to a mammal in need of such treatment, either simultaneously or sequentially, (i) a therapeutically effective amount of a taxane derivative, a platinium coordination complex selected from the group consisting of carboplatin, tetraplatin, and topotecan, a nucleoside analog selected from the group consisting of gemcitabine hydrochloride and 5-FU, an anthracycline, a topoisomerase selected from the group consisting of etoposide, teniposide, amsacrine, topotecan, and Camptosar(R), an aromatase inhibitor; and (ii) a therapeutically effective amount of an isothiazole derivative. The combinations of the present invention may optionally include an anti-hypertensive agent. This invention also relates to pharmaceutical compositions useful in the treatment of hyperproliferative diseases in mammals, containing such combinations. The present invention also relates to kits having a first compartment with a compound of formula 1 and a second compartment containing a taxane derivative, a platinum coordination complex, a nucleoside analog, an anthracycline, a topoisomerase inhibitor, or an aromatase inhibitor and a third compartment containing an anti-hypertensive agent.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_HK1079106A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMPOSITION FOR TREATING HYPERPROLIFERATIVE DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A20%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAREN%20JEAN%20FERRANTE&rft.date=2006-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHK1079106A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true